✨ Your Portfolio is fetched and updated from zerodha.
Nano Miscellaneous
Market Cap
₹28 Cr.
P/E
71.70
  • Vaxfab Enterprise
  • Sanblue Corporation
  • Rubra Medicaments

FAQs on Vaxfab Enterprises Ltd. Shareprice

Vaxfab Enterprise has given lower returns compared to its competitors.
Vaxfab Enterprise has grown at ~35.38% over the last 4yrs while peers have grown at a median rate of 36.71%

Vaxfab Enterprise is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Vaxfab Enterprise is 73.15, while 3 year average PE is 40.59.
Also latest EV/EBITDA of Vaxfab Enterprise is 18.63 while 3yr average is 35.39.

Growth Table

  • Vaxfab Enterprises Ltd.
  • Sanblue Corporation
  • Rubra Medicaments

Balance Sheet

  • Vaxfab Enterprises Ltd.
  • Sanblue Corporation
  • Rubra Medicaments

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Vaxfab Enterprises Ltd.
  • Sanblue Corporation
  • Rubra Medicaments

Cash Flow

  • Vaxfab Enterprises Ltd.
  • Sanblue Corporation
  • Rubra Medicaments

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Vaxfab Enterprises Ltd.
  • Sanblue Corporation
  • Rubra Medicaments

Quarterly Results

  • Vaxfab Enterprises Ltd.
  • Sanblue Corporation
  • Rubra Medicaments

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Vaxfab Enterprises Ltd. Financials

Balance sheet of Vaxfab Enterprise is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Vaxfab Enterprise is increasing.
Latest net debt of Vaxfab Enterprise is -₹0.4 Crs as of Mar-24.
This is greater than Mar-23 when it was -₹7.83 Crs.

The profit is oscillating.
The profit of Vaxfab Enterprise is -₹3.53 Crs for Mar 2024, ₹0.33 Crs for Mar 2023 and ₹0 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vaxfab Enterprise latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Capital Work in Progress, Accounts Receivable, Short Term Loans & Advances

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech